FDA is seeking public input and has announced the availability of a Draft Guidance on: Hypertension- Developing Fixed-Dose Combination Drugs for Treatment. This draft guidance will help with the development of fixed-dose combination drugs for the treatment of hypertension.
Managing patients who have hypertension often require that healthcare providers prescribe multiple drugs to control their blood pressure and fixed-dose drug combinations may help simplify their treatment, increase adherence and minimize potential side effects. The guidance focuses on development of fixed dose two-drug combinations of previously approved drugs.
You may read the entire notice in the Federal Register and submit formal comments by March 27, 2018.
Managing patients who have hypertension often require that healthcare providers prescribe multiple drugs to control their blood pressure and fixed-dose drug combinations may help simplify their treatment, increase adherence and minimize potential side effects. The guidance focuses on development of fixed dose two-drug combinations of previously approved drugs.
You may read the entire notice in the Federal Register and submit formal comments by March 27, 2018.
Steve Morin
Office of Health and Constituent Affairs
Food and Drug Administration
Office of Health and Constituent Affairs
Food and Drug Administration
Visit the FDA Patient Network for more Information about the FDA Cardiovascular Liaison Program
.png)
No hay comentarios:
Publicar un comentario